Literature DB >> 32638404

LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.

Ting Hao1, Shu Huang2, Fangzheng Han1.   

Abstract

LncRNA LINC-PINT acts as an important regulator in the development of many cancers. The current study aimed to explore the role of LINC-PINT in the progression of ovarian cancer (OC). LINC-PINT expression level in different FIGO stages of OC and its adjacent tissues, normal HOSE and OC cell lines (A2780, SKOV3, OVCAR3 and HO-8910) was determined by qRT-PCR. Survival analysis on LINC-PINT and OC patients was conducted by Kaplan-Meier. CCK-8, flow cytometry, wound-healing, Transwell assays and western blot were performed to detect the effects of LINC-PINT on proliferation, apoptosis, migration, invasion and EMT process in OC cells. Target gene of LINC-PINT was predicted by Starbase and verified by dual-luciferase reporter assay. The expression of miR-374a-5p in normal and OC tissues, LINC-PINT- or siLINC-PINT-modified OC cells was determined. Moreover, rescue assay was carried out to confirm whether LINC-PINT contributes to the development of OC cells through targeting miR-374a-5p. Low expression of LINC-PINT was observed in OC tissues and cells, noticeably, LINC-PINT expression was even lower in OC tissues with higher FIGO stage. Increased LINC-PINT expression significantly inhibited cell proliferation, promoted apoptosis and suppressed migration, invasion and EMT process, while silencing of LINC-PINT caused the opposite results. Moreover, LINC-PINT sponged miR-374a-5p and overexpressed miR-374a-5p attenuated the effect of up-regulated LINC-PINT on cell viability, migration, invasion and apoptosis. LINC-PINT acts as a tumour suppressor, as it could inhibit cell proliferation, migration, invasion and EMT process, and promote cell apoptosis through down-regulating miR-374a-5p. SIGNIFICANCE OF THE STUDY: Ovarian cancer (OC), which is a frequently diagnosed tumour in female reproductive organs, has a high incidence rate behind cervical cancer and endometrial cancer. LncRNA LINC-PINT acts as an important regulator in the development of many cancers. The current study aimed to explore the role of LINC-PINT in the progression of ovarian cancer (OC) and found that LINC-PINT inhibited cell proliferation, migration invasion and EMT process of OC cell via regulating miR-374a-5p; it might be a potential target for OC treatment.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  LINC-PINT; miR-374a-5p; migration; ovarian cancer; proliferation

Mesh:

Substances:

Year:  2020        PMID: 32638404     DOI: 10.1002/cbf.3565

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  5 in total

1.  TWIST1 methylation by SETD6 selectively antagonizes LINC-PINT expression in glioma.

Authors:  Lee Admoni-Elisha; Tzofit Elbaz; Anand Chopra; Guy Shapira; Mark T Bedford; Christopher J Fry; Noam Shomron; Kyle Biggar; Michal Feldman; Dan Levy
Journal:  Nucleic Acids Res       Date:  2022-06-13       Impact factor: 19.160

2.  dbEssLnc: A manually curated database of human and mouse essential lncRNA genes.

Authors:  Ying-Ying Zhang; Wen-Ya Zhang; Xiao-Hong Xin; Pu-Feng Du
Journal:  Comput Struct Biotechnol J       Date:  2022-05-23       Impact factor: 6.155

3.  LINC00518 Promotes Cell Proliferation by Regulating the Cell Cycle of Lung Adenocarcinoma Through miR-185-3p Targeting MECP2.

Authors:  Xu Han; Jixiang Wu; Yajun Zhang; Jianxiang Song; Zhan Shi; Huiwen Chang
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

4.  LINC-DUBR Suppresses Malignant Progression of Ovarian Cancer by Downregulating miR-107 to Induce SMAC Expression.

Authors:  Zhehui Han; Dan Li; Yun Yang; Hong Zhang
Journal:  J Healthc Eng       Date:  2022-03-03       Impact factor: 2.682

5.  H3K27ac-induced lncRNA PAXIP1-AS1 promotes cell proliferation, migration, EMT and apoptosis in ovarian cancer by targeting miR-6744-5p/PCBP2 axis.

Authors:  Yimin Ma; Wei Zheng
Journal:  J Ovarian Res       Date:  2021-06-09       Impact factor: 5.506

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.